AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2016
Mar 8, 2016
29755_dirs_2016-03-08_f2776b18-4251-4788-9dba-63f2a1e917ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-03-08
Reporting Person: Schumacher Laura J (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-08 | Common stock, $0.01 par value | S | 19900 | $56.09 | Disposed | 199238 | Direct |
| 2016-03-08 | Common stock, $0.01 par value | S | 3400 | $56.10 | Disposed | 195838 | Direct |
| 2016-03-08 | Common stock, $0.01 par value | S | 500 | $56.11 | Disposed | 195338 | Direct |
| 2016-03-08 | Common stock, $0.01 par value | S | 300 | $56.12 | Disposed | 195038 | Direct |
| 2016-03-08 | Common stock, $0.01 par value | S | 800 | $56.13 | Disposed | 194238 | Direct |
| 2016-03-08 | Common stock, $0.01 par value | S | 100 | $56.15 | Disposed | 194138 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4